
Fidelity Investments’s Harmony Biosciences HRMY Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $148M | Sell |
4,688,192
-654,333
| -12% | -$20.7M | 0.01% | 949 |
|
2025
Q1 | $177M | Buy |
5,342,525
+12,623
| +0.2% | +$419K | 0.01% | 840 |
|
2024
Q4 | $183M | Buy |
5,329,902
+101,182
| +2% | +$3.48M | 0.01% | 858 |
|
2024
Q3 | $209M | Sell |
5,228,720
-9,184
| -0.2% | -$367K | 0.01% | 811 |
|
2024
Q2 | $158M | Sell |
5,237,904
-17,614
| -0.3% | -$531K | 0.01% | 869 |
|
2024
Q1 | $176M | Sell |
5,255,518
-21,307
| -0.4% | -$715K | 0.01% | 838 |
|
2023
Q4 | $170M | Sell |
5,276,825
-173,384
| -3% | -$5.6M | 0.01% | 808 |
|
2023
Q3 | $179M | Sell |
5,450,209
-20,038
| -0.4% | -$657K | 0.02% | 739 |
|
2023
Q2 | $192M | Sell |
5,470,247
-121,328
| -2% | -$4.27M | 0.02% | 737 |
|
2023
Q1 | $183M | Buy |
5,591,575
+8,847
| +0.2% | +$289K | 0.02% | 745 |
|
2022
Q4 | $308M | Sell |
5,582,728
-32,611
| -0.6% | -$1.8M | 0.03% | 550 |
|
2022
Q3 | $249M | Buy |
5,615,339
+188,557
| +3% | +$8.35M | 0.03% | 594 |
|
2022
Q2 | $265M | Buy |
5,426,782
+529,600
| +11% | +$25.8M | 0.03% | 605 |
|
2022
Q1 | $238M | Buy |
4,897,182
+689,583
| +16% | +$33.5M | 0.02% | 697 |
|
2021
Q4 | $179M | Buy |
4,207,599
+78,648
| +2% | +$3.35M | 0.01% | 847 |
|
2021
Q3 | $158M | Sell |
4,128,951
-812,576
| -16% | -$31.1M | 0.01% | 908 |
|
2021
Q2 | $139M | Sell |
4,941,527
-2,308,914
| -32% | -$65.2M | 0.01% | 981 |
|
2021
Q1 | $240M | Sell |
7,250,441
-676,183
| -9% | -$22.3M | 0.02% | 712 |
|
2020
Q4 | $274M | Sell |
7,926,624
-1,137,412
| -13% | -$39.3M | 0.02% | 622 |
|
2020
Q3 | $280M | Buy |
+9,064,036
| New | +$280M | 0.03% | 512 |
|